<SEC-DOCUMENT>0001610618-25-000032-index.html : 20250415
<SEC-HEADER>0001610618-25-000032.hdr.sgml : 20250415
<ACCEPTANCE-DATETIME>20250415172712
ACCESSION NUMBER:		0001610618-25-000032
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250618
FILED AS OF DATE:		20250415
DATE AS OF CHANGE:		20250415

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cidara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001610618
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				461537286
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36912
		FILM NUMBER:		25840678

	BUSINESS ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-752-6170

	MAIL ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	K2 THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20140611
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>cdtx-20250415.htm
<DESCRIPTION>PRELIMINARY PROXY STATEMENT
<TEXT>
Document 1 - file: cdtx-20250415.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>2 <FILENAME>cdtx-20250415.xsd <DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT <TEXT> Document 2 - file: cdtx-20250415.xsd
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>cdtx-20250415_g1.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: cdtx-20250415_g1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>cdtx-20250415_g2.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: cdtx-20250415_g2.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>cdtx-20250415_g3.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: cdtx-20250415_g3.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>cdtx-20250415_g4.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: cdtx-20250415_g4.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>cdtx-20250415_g5.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: cdtx-20250415_g5.jpg
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>R2.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: R2.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>R3.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: R3.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>12 <FILENAME>R4.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: R4.htm
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>13 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>15 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 15 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>17 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 17 - file: FilingSummary.html
Document 17 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>19 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 19 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>20 <FILENAME>0001610618-25-000032-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 20 - file: 0001610618-25-000032-xbrl.zip
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>21 <FILENAME>cdtx-20250415_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 21 - file: cdtx-20250415_htm.html
Document 21 - RAW XML: cdtx-20250415_htm.xml
</DOCUMENT> </SEC-DOCUMENT>